Announced Wed, 31 Dec · 24:46 IST

The Company hereby submit intimation regarding increase and revision in managerial remuneration pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

At its 44th Annual General Meeting held on 30 December 2025, shareholders approved an increase in the overall managerial remuneration ceiling to exceed 11% of the company's net profits. They also approved revisions to the remuneration of three directors: Managing Director Mr. Tosh Kumar Jain, Whole-time Director Mr. Arihant Kumar Jain, and Whole-time Director Mrs. Monika Jain — all from the Jain family who run the company. The resolution cleared the 11% statutory limit for managerial payout, giving the board flexibility on compensation. The Ayurvedic and herbal products maker (established 1901, BSE scrip code 531521) did not disclose the new salary amounts. The AGM ran from 3:00 PM to 4:30 PM and all business was approved.

Likely market impact

Higher payouts to promoters-directors will increase the company's fixed employee costs and could weigh on margins, though shareholders have signalled comfort by approving the hike. Retail investors should watch future quarterly expenses to gauge the effect on profitability.